IRIS
MARTI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.606
EU - Europa 2.548
AS - Asia 1.001
SA - Sud America 16
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 11.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.563
IT - Italia 969
CN - Cina 609
UA - Ucraina 506
TR - Turchia 303
DE - Germania 286
GB - Regno Unito 224
BE - Belgio 123
RO - Romania 110
SE - Svezia 105
FI - Finlandia 101
FR - Francia 44
PL - Polonia 40
CA - Canada 39
IN - India 22
IR - Iran 17
JP - Giappone 11
NL - Olanda 11
BR - Brasile 9
PK - Pakistan 9
ES - Italia 8
RU - Federazione Russa 7
AE - Emirati Arabi Uniti 6
VN - Vietnam 6
AU - Australia 5
HU - Ungheria 5
KR - Corea 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
MX - Messico 2
TW - Taiwan 2
CO - Colombia 1
CR - Costa Rica 1
EE - Estonia 1
ID - Indonesia 1
KH - Cambogia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SG - Singapore 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 11.182
Salva come PNG Salva come JPEG
Città #
Fairfield 1.078
Woodbridge 978
Chandler 604
Houston 589
Jacksonville 539
Ashburn 444
Seattle 409
Ann Arbor 393
Wilmington 388
Cambridge 378
Ferrara 204
Izmir 193
Beijing 192
Princeton 158
Nanjing 141
Brussels 122
Milan 107
San Diego 107
Boardman 74
Redwood City 68
Hebei 42
Bremen 41
Shenyang 40
Falls Church 36
Warsaw 32
Nanchang 27
Norwalk 27
Tianjin 27
Mountain View 26
Washington 26
Jiaxing 25
Bologna 23
San Mateo 22
London 21
Changsha 20
Auburn Hills 19
Leawood 18
Dearborn 14
Augusta 13
Jinan 13
Los Angeles 13
Rome 13
Ardabil 12
Helsinki 11
Kunming 11
Zhengzhou 11
Ottawa 10
Redmond 10
Clifton Park 9
Guangzhou 9
New York 9
Serra 9
Tappahannock 9
Guarda Veneta 8
Mississauga 8
Taizhou 8
Timisoara 8
Verona 8
Cagliari 7
Indiana 7
Minerbe 7
Ningbo 7
Orange 7
Winchester 7
Chiswick 6
Daly City 6
Dong Ket 6
Munich 6
Pune 6
Tokyo 6
Dubai 5
Ferrara di Monte Baldo 5
Haikou 5
Hangzhou 5
Hanover 5
Lahore 5
Lanzhou 5
Mumbai 5
Brooklyn 4
Castenaso 4
Chatsworth 4
Chicago 4
Des Moines 4
Lima 4
Monteveglio 4
Polska 4
Saint-Fons 4
Shanghai 4
Addison 3
Amsterdam 3
Bangalore 3
Florence 3
Fuzhou 3
Kuala Lumpur 3
Nagareyama 3
Naples 3
Napoli 3
Ocean Springs 3
Osnago 3
Padova 3
Totale 8.048
Salva come PNG Salva come JPEG
Nome #
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 375
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 219
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 184
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 176
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 170
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 154
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 150
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 142
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 138
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 138
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 136
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 127
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 127
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 127
Loss of cortical GABA terminals in Unverricht–Lundborg disease 124
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 123
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 122
null 121
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 118
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 118
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 117
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 116
null 113
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 111
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 110
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 110
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 110
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 108
null 108
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 108
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 108
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 105
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 103
JWH-018 impairs sensorimotor functions in mice 103
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 102
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 102
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: An electrophysiological study 101
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 100
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 100
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 100
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 99
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. 98
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 97
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 97
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 95
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 95
Antagonisti dei recettori NOP e loro usi terapeutici 94
null 94
null 92
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata: A microdialysis study in the awake freely moving rat. 92
null 92
null 91
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 91
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 90
null 89
null 88
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 88
null 87
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 87
null 87
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat. 85
null 84
Novel Synthetic Opioids: The Pathologist's Point of View 84
null 82
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 80
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 79
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin 78
Cutaneous miRNAs expression in human hanging injuries 78
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 76
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 75
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 75
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 72
Studio degli effetti acuti e cronici e delle proprietà d’abuso del cannabinoide sintetico JWH-018: un approccio multidisciplinare 72
Un distillato Bohémienne tuttora famoso: l’assenzio 72
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 72
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors 72
Droghe da stupro: il GHB ed i suoi analoghi 71
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 70
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 69
Reply to "MDPV-induced aggression in humans not established" 69
Application of 13 loci STR multiplex for the cannabis sativa genotyping 68
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 67
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 66
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 66
Ayahuasca: il vino dell'anima 65
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 60
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 59
Application of 13 loci STR multiplex for cannabis sativa genotyping 59
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 58
Reciprocal dopamine-glutamate modulation of release in the basal ganglia 58
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 58
Studio multidisciplinare degli effetti farmaco-tossicologici e fisiopatologici di nuove molecole psicoattive sintetiche (novel synthetic drugs, ns-drugs) per comprendere le possibili alterazioni psico-fisiche nei guidatori di autoveicoli 58
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 58
Mrna profiling in casework analyses 58
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 57
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 57
null 56
Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe 56
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesia in a rat model of Parkinson�s Disease 55
Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa 55
Totale 9.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 388
Totale 32.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.408 0 0 0 54 15 20 137 7 110 260 279 526
2019/20202.379 336 78 65 316 152 252 206 245 229 245 190 65
2020/20212.265 179 137 190 247 165 176 96 283 84 294 271 143
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.679 179 145 81 150 232 177 109 153 230 32 133 58
2023/2024307 98 141 68 0 0 0 0 0 0 0 0 0
Totale 11.433